Biogenerics: Europe takes another step forward while the FDA dives for cover-Reference-Cited by-同舟云学术

Biogenerics: Europe takes another step forward while the FDA dives for cover

Published:2004-10 Issue:19 Volume:9 Page:817-820
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Chamberlain Paul

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference4 articles.

1. Regulatory and development issues in the demonstration of therapeutic equivalence for multisource biotech-derived pharmaceuticals;Zeild;Drug Inf. J,2000

2. Presages to the coming war over generic biologics;Karsat;Journal of Generic Medicines,2004

3. Walker, E. (2004) FDA follow-on biologics guidance delayed, agency tells BIO.Health News Daily 9 June

4. BIOTECHNOLOGY Industry Organization (2003) BIO Citizen Petition: follow-on therapeutic proteins http://www.bio.org/healthcare/pharmaceutical/BIO_CP--FINAL_DRAFT_4_22_03.pdf)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilars;Pharmaceutical Sciences Encyclopedia;2010-03-15

2. Near-Infrared Reflectance Spectroscopy-Based Methods for Phytase Registration in Feed Industry;Journal of Agricultural and Food Chemistry;2007-08-23

3. Post-translational modifications in the context of therapeutic proteins;Nature Biotechnology;2006-10

4. Factors of importance for a successful delivery system for proteins;Expert Opinion on Drug Delivery;2005-11

5. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind study;BMC Nephrology;2005-05-23